Novel therapies targeting the apoptosis pathway fo...[Curr Treat Options Oncol. 2007]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Curr Treat Options Oncol. 2007 Aug;8(4):277-86. Links

Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemia.

Schimmer AD.

Ontario Cancer Institute, Princess Margaret Hospital, 610 University Ave, M5G 2M9, Toronto, ON, Canada. aaron.schimmer@utoronto.ca

Defects in the core regulators of the apoptosis pathway contribute to chemoresistance and poor outcomes in patients with acute myeloid leukemia (AML). To overcome these defects, novel molecules that target key proteins in the mitochondrial, death receptor, and convergence pathways of caspase activation are being developed. This review will highlight selected molecules including Bcl-2 and XIAP inhibitors that are advanced stages of development and have entered clinical trial for AML. In addition, this review will discuss how these novel therapies are being used as chemical probes to better understand the biology of the apoptosis pathway.

PMID: 18004514 [PubMed - indexed for MEDLINE]

ReviewInduction of apoptosis in lymphoid and myeloid leukemia.
Curr Oncol Rep. 2006 Nov; 8(6):430-6.

[Curr Oncol Rep. 2006]
ReviewDeregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.
Curr Cancer Drug Targets. 2008 May; 8(3):207-22.

[Curr Cancer Drug Targets. 2008]
A celecoxib derivative inhibits focal adhesion signaling and induces caspase-8-dependent apoptosis in human acute myeloid leukemia cells.
Int J Cancer. 2008 Jul 1; 123(1):217-26.

[Int J Cancer. 2008]
Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.
Leukemia. 2008 Apr; 22(4):808-18. Epub 2008 Jan 17.

[Leukemia. 2008]
The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Haematologica. 2008 Jan; 93(1):57-66.

[Haematologica. 2008]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemi...Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemia.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemia.

Related articles

Recent Activity